Autologous HER2 CMV bispecific CAR T cells are safe and demonstrate clinical benefit for glioblastoma in a Phase I trial.
暂无分享，去创建一个
R. Grossman | S. Powell | H. Heslop | C. Rooney | W. Wels | S. Gottschalk | A. Gee | G. Dotti | A. Ashoori | J. Hicks | N. Ahmed | D. Baskin | K. Bielamowicz | D. Landi | M. Hegde | A. Wakefield | P. New | M. Kalra | O. Diouf | Zhongzhen Yi | C. Gerken | V. Brawley | Jonathan Y Zhang | A. Ghazi | Y. Kew | Amanda Wakefield